Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne T Reutens

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nephron. Clinical Practice|February 5, 2011
Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathyDavid K Packham, Sara E Ivory, Anne T Reutens, et al.
Journal of Hypertension|February 25, 2011
Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab studyKatja van den Hurk, Dianna J Magliano, Marjan Alssema, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 1, 2026
Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trialNatalie Nanayakkara, Michael L H Huang, Andre La Gerche, et al.
Cancer Research|June 18, 2003
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesisMark D'Amico, Kongming Wu, Dolores Di Vizio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2011
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trialEdmund J Lewis, Julia B Lewis, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyDavid K Packham, Rory Wolfe, Anne T Reutens, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Pyridorin in type 2 diabetic nephropathyEdmund J Lewis, Tom Greene, Samuel Spitalewiz, et al.
Diabetes Research and Clinical Practice|July 13, 2012
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practiceAnne T Reutens, Richard Hutchinson, Ta Van Binh, et al.
Diabetologia|October 20, 2017
Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humansRebecca K C Loh, Melissa F Formosa, Nina Eikelis, et al.
Diabetologia|December 10, 2017
Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humansRebecca K C Loh, Melissa F Formosa, Nina Eikelis, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nephron. Clinical Practice|February 5, 2011
Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathyDavid K Packham, Sara E Ivory, Anne T Reutens, et al.
Journal of Hypertension|February 25, 2011
Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab studyKatja van den Hurk, Dianna J Magliano, Marjan Alssema, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 1, 2026
Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trialNatalie Nanayakkara, Michael L H Huang, Andre La Gerche, et al.
Cancer Research|June 18, 2003
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesisMark D'Amico, Kongming Wu, Dolores Di Vizio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2011
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trialEdmund J Lewis, Julia B Lewis, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyDavid K Packham, Rory Wolfe, Anne T Reutens, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2011
Pyridorin in type 2 diabetic nephropathyEdmund J Lewis, Tom Greene, Samuel Spitalewiz, et al.
Diabetes Research and Clinical Practice|July 13, 2012
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practiceAnne T Reutens, Richard Hutchinson, Ta Van Binh, et al.
Diabetologia|October 20, 2017
Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humansRebecca K C Loh, Melissa F Formosa, Nina Eikelis, et al.
Diabetologia|December 10, 2017
Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humansRebecca K C Loh, Melissa F Formosa, Nina Eikelis, et al.
Pageof 3